Company Cash on Hand: CRISPR Therapeutics AG (CRSP)

CRSP (CRISPR Therapeutics) - company brandmark

CRISPR Therapeutics AG (CRSP) is a gene-editing leader holding patents for the CRISPR/Cas9 method and the successful drug Casgevy. On GURU.Markets, the company's cash reserves demonstrate liquidity for M&A transactions, with the parameter stabilizing at 2.26. However, the high cost of therapy and R&D expenditures create financial pressure, despite the company's flawless image as an innovator in the eyes of the global scientific community.

CRISPR Therapeutics Inc - CRSP Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Metric breakdowns and analytics for CRISPR Therapeutics Inc (CRSP)

- company stock exchange capitalization indicators:
Basic company analysis:CRISPR Therapeutics AG CRSP
Brand item of CRISPR Therapeutics

When constructing a long-term portfolio, it is critical to assess liquidity via free cash flow, which determines an issuer's ability to fund development without resorting to expensive debt capital. This metric measures the net cash balance, which in the case of CRISPR Therapeutics AG (CRSP) confirms a transition toward self-sufficiency through drug commercialization, while the trend in cash assets illustrates the current resilience of the business.

Direct competitors

Company Cash Volume TEM|QGEN - Company Cash Reserve|ionispharma.com - Company Cash on Hand|Company Cash Balance RGEN|Avidity Corp - Company Cash Volume|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume